Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-21 @ 10:12 PM
Study NCT ID:
NCT02824666
Status:
COMPLETED
Last Update Posted:
2017-07-17
First Post:
2016-06-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate D2 Receptor Occupancy Following Single Intravenous Administration of ATI-9242
Sponsor:
Braeburn Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Schizophrenia | View |
Keywords: